Missed Anti-Seizure Medication Doses in Care Settings: What Your Policy Should Say

Anti-seizure medications (ASMs) are widely treated as time-critical medicines. A missed or late dose can increase the risk of seizures. Every care provider supporting people with epilepsy needs a clear medication policy covering prevention, immediate escalation for professional advice, recording, and learning from incidents. Staff should never decide on their own whether to give a late or extra dose.

Why missed doses matter

ASMs work best when they are taken consistently and on time, because this keeps medication levels in the body stable. When a dose is missed or significantly delayed, those levels can drop and seizure risk can rise.

Missed doses are one of the most common causes of breakthrough seizures. In care settings, they are also one of the most preventable. A robust policy protects the people you support and helps you show that medicines are managed safely.

The regulatory context

Safe management of medicines is a core expectation of every UK care regulator:

• England: the Care Quality Commission (CQC), under Regulation 12 (safe care and treatment)
• Scotland: the Care Inspectorate
• Wales: Care Inspectorate Wales (CIW)
• Northern Ireland: the Regulation and Quality Improvement Authority (RQIA)

NICE guidance on managing medicines in care homes (SC1) and for adults receiving social care in the community (NG67) also sets out good practice for medicine policies, recording and staff competency.

Common causes of missed doses

Understanding why doses are missed helps you prevent them. Common causes include:

• Stock running out, including during national supply shortages
• Refusal, where the person declines their medication
• The person being unavailable, for example asleep, out on an activity or away from the service
• Vomiting shortly after a dose
• Swallowing difficulties
• Transitions of care, such as hospital admission, discharge or moving between services
• Recording errors, including gaps in the Medication Administration Record (MAR)
• Brand or formulation changes that cause confusion about which medicine to give

What your policy should include

1. Prevention

• Stock checks with reorder points that allow for pharmacy lead times
• A clear process for sourcing medication urgently if stock runs low
• Planning for activities, outings, home visits and overnight stays
• Brand consistency where the prescriber has specified a brand
• Electronic MAR alerts or equivalent checks for time-critical doses

2. Immediate response to a missed or late dose

Your policy should say clearly what staff do as soon as a missed or late dose is discovered:

• Do not give a late dose or a double dose without professional advice. The right action depends on the specific medicine, the dose and how much time has passed.
• Seek advice promptly from the prescriber or a pharmacist. Out of hours, contact NHS 111 or the local GP out-of-hours service.
• Follow the advice given and record it, including who gave it and when.
• Increase observation for seizure activity in line with the person’s care plan.

3. Refusal

If a person declines their medication, staff should:

• try again at a suitable time within the safe window, if the prescriber or pharmacist advises this
• explore and record the reasons for refusal
• consider whether the person has capacity to make this decision

Repeated refusal should be escalated to the prescriber. Covert administration must only ever happen under a formal, documented process involving the prescriber, a pharmacist and a best-interests or equivalent legal decision.

4. Vomiting

If a person vomits after taking their medication, staff should seek advice before giving another dose. Record the time of the dose and the time of vomiting.

5. Recording and reporting

Every missed or late dose should be recorded on the MAR and reported through your incident process. The record should include:

• what happened and when
• the advice sought
• the action taken
• any seizures that followed

Managers should consider whether the incident meets the threshold for a safeguarding referral, a notification to the regulator or the duty of candour. Repeated or deliberate omissions are a safeguarding concern.

6. Learning from incidents

Review incidents for patterns, such as particular shifts, staff members, times of day or ordering problems. Share what you learn with the team and update procedures where needed.

7. Staff competency

Staff who administer ASMs should:

• be trained in medicines administration
• understand why ASMs are time-critical
• know exactly what to do when a dose is missed

Competency should be assessed and reassessed, usually at least annually, and recorded.

Communication and handover

Missed doses should always be passed on at shift handover, so the next team knows to watch for seizures and to follow up on any advice received. Families and the person’s healthcare team should be informed in line with the person’s wishes and your policy.

Frequently asked questions

Are anti-seizure medications time-critical?

ASMs are widely treated as time-critical medicines, because missed or delayed doses can increase seizure risk. The person’s prescriber or pharmacist can confirm the acceptable timing window for their specific medicines.

Can care staff give a missed dose late?

Only on the advice of a prescriber, pharmacist or NHS 111. Staff should not make this decision alone.

Is a missed dose a safeguarding issue?

A single missed dose is a medication incident and should be recorded and reviewed. Repeated, unexplained or deliberate omissions may be a safeguarding concern and should be referred under your safeguarding procedures.